Submit an Article

Navigate

Submit an Article

Online ISSN: 1945-4589

Research Paper|Volume 13, Issue 12|pp. 16696–16712

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma

Back to articleFigure 9(9 of 11)

−100%+

Figure 9.Survival analysis of EC patients belonging to different ICG expression subgroups. (A) Kaplan-Meier survival curves show OS of EC patients belonging to high or low IDO1 and TNFRSF14 expression groups. (B) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CD274 and TNFRSF14 expression groups. (C) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CTLA4 and TNFRSF14 expression groups. (D) Kaplan-Meier survival curves show OS of EC patients belonging to IDO1^lowTNFRSF14^high and IDO1^lowTNFRSF14^low expression groups. (E) Kaplan-Meier survival curves show OS of EC patients belonging to CD274^lowTNFRSF14^high and CD274^lowTNFRSF14^low expression groups. (F) Kaplan-Meier survival curves show OS of EC patients belonging to CTLA4^lowTNFRSF14^high and CTLA4^lowTNFRSF14^low expression groups. The abscissa represents survival time, and the ordinate represents overall survival.